- Home
- CHNR vs SONN Comparison
CHNR vs SONN Comparison
Compare CHNR & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHNR
- SONN
- Stock Information
- Founded
- CHNR N/A
- SONN N/A
- Country
- CHNR Hong Kong
- SONN United States
- Employees
- CHNR N/A
- SONN N/A
- Industry
- CHNR Precious Metals
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- CHNR Basic Materials
- SONN Health Care
- Exchange
- CHNR Nasdaq
- SONN Nasdaq
- Market Cap
- CHNR 5.2M
- SONN 4.6M
- IPO Year
- CHNR 1995
- SONN N/A
- Fundamental
- Price
- CHNR $0.56
- SONN $1.29
- Analyst Decision
- CHNR
- SONN Strong Buy
- Analyst Count
- CHNR 0
- SONN 2
- Target Price
- CHNR N/A
- SONN $38.00
- AVG Volume (30 Days)
- CHNR 50.3K
- SONN 35.6K
- Earning Date
- CHNR 05-15-2025
- SONN 05-13-2025
- Dividend Yield
- CHNR N/A
- SONN N/A
- EPS Growth
- CHNR N/A
- SONN N/A
- EPS
- CHNR N/A
- SONN N/A
- Revenue
- CHNR N/A
- SONN $1,000,000.00
- Revenue This Year
- CHNR N/A
- SONN $5,376.22
- Revenue Next Year
- CHNR N/A
- SONN N/A
- P/E Ratio
- CHNR N/A
- SONN N/A
- Revenue Growth
- CHNR N/A
- SONN 978.39
- 52 Week Low
- CHNR $0.45
- SONN $1.10
- 52 Week High
- CHNR $1.13
- SONN $16.00
- Technical
- Relative Strength Index (RSI)
- CHNR 52.58
- SONN 47.13
- Support Level
- CHNR $0.51
- SONN $1.21
- Resistance Level
- CHNR $0.66
- SONN $1.37
- Average True Range (ATR)
- CHNR 0.05
- SONN 0.07
- MACD
- CHNR 0.00
- SONN -0.01
- Stochastic Oscillator
- CHNR 35.87
- SONN 27.59
About CHNR China Natural Resources Inc.
China Natural Resources Inc is an investment holding company. It principally engaged in the exploration and mining and wastewater treatment businesses in the People's Republic of China. The company has two operating segments: (i) Wastewater treatment segment, which consists of sales of assembled equipment, provision of construction service, and participation in PPP projects as an operator (ii) Exploration and mining segment, which consists of the exploration of lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and the trading of copper ores products. It earns the majority of its revenue from the Wastewater treatment segment.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.